Request for Project Proposals: Production of Drug Substances and Drug Products at Commercial Scale – Anti-Microbials and Large Volume Parenterals
The Department of Health and Human Services (HHS) Defense Production Act (DPA) Title III Program is interested in submissions that strengthen the Nation’s security of supply for at least one (1) key starting material (KSM), drug substance, and/or drug product identified within the FDA’s List of Essential Medicines, with a preference for submissions that focus on Anti-Microbials and Large Volume Parenterals.
Details
RPP Released: February 6, 2026
Amendment 1: Released March 5, 2026
Submissions Due: March 16, 2026 1PM ET